70 related articles for article (PubMed ID: 11877041)
1. [Multivariate analysis of prognostic factors in Philadelphia chromosome-positive chronic granulocytic leukemia].
Hao C; Wang Y; Li Q; Liu B; Qian L
Zhonghua Xue Ye Xue Za Zhi; 2001 Jan; 22(1):5-8. PubMed ID: 11877041
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic significance of some clinical and laboratory parameters in patients with chronic myelogenous leukemia].
Sledziowski P; Lisiewicz J
Przegl Lek; 1995; 52(2):42-6. PubMed ID: 7784614
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the impact of imatinib mesylate therapy on the prognosis of patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha regimens for early chronic phase.
Kantarjian H; O'Brien S; Cortes J; Shan J; Giles F; Garcia-Manero G; Verstovsek S; Faderl S; Rios MB; Talpaz M
Cancer; 2003 Oct; 98(7):1430-7. PubMed ID: 14508830
[TBL] [Abstract][Full Text] [Related]
4. [Multivariate analysis of prognostic factors influencing survival in chronic myelogenous leukemia].
Sakamoto S; Kurata H; Miwa A
Rinsho Ketsueki; 1989 Aug; 30(8):1180-4. PubMed ID: 2601030
[TBL] [Abstract][Full Text] [Related]
5. Multivariate analysis of risk factors for survival and relapse in chronic granulocytic leukemia following allogeneic marrow transplantation: impact of disease related variables (Sokal score).
Bacigalupo A; Gualandi F; Van Lint MT; Sessarego M; Frassoni F; Occhini D; Lamparelli T; Oneto R; Vitale V; Corvo R
Bone Marrow Transplant; 1993 Nov; 12(5):443-8. PubMed ID: 8298554
[TBL] [Abstract][Full Text] [Related]
6. Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up results.
Kantarjian HM; Talpaz M; O'Brien S; Smith TL; Giles FJ; Faderl S; Thomas DA; Garcia-Manero G; Issa JP; Andreeff M; Kornblau SM; Koller C; Beran M; Keating M; Rios MB; Shan J; Resta D; Capdeville R; Hayes K; Albitar M; Freireich EJ; Cortes JE
Clin Cancer Res; 2002 Jul; 8(7):2177-87. PubMed ID: 12114418
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.
Onida F; Ball G; Kantarjian HM; Smith TL; Glassman A; Albitar M; Scappini B; Rios MB; Keating MJ; Beran M
Cancer; 2002 Oct; 95(8):1673-84. PubMed ID: 12365015
[TBL] [Abstract][Full Text] [Related]
8. [Long-term survival in chronic myeloid leukemia: frequency and fundamental characteristics in a series of 100 patients].
Cervantes F; Bosch F; Terol MJ; Pereira A; Rozman C
Sangre (Barc); 1993 Apr; 38(2):93-6. PubMed ID: 8516734
[TBL] [Abstract][Full Text] [Related]
9. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
[TBL] [Abstract][Full Text] [Related]
10. Multivariate analysis of prognostic factors in chronic myelogenous leukemia.
Jootar S; Chuncharunee S; Ongphiphaphadhanakul B; Atichartakarn V
J Med Assoc Thai; 1990 Dec; 73(12):662-9. PubMed ID: 2086713
[TBL] [Abstract][Full Text] [Related]
11. Clinical and prognostic features of Nigerians with chronic myeloid leukemia.
Boma PO; Durosinmi MA; Adediran IA; Akinola NO; Salawu L
Niger Postgrad Med J; 2006 Mar; 13(1):47-52. PubMed ID: 16633379
[TBL] [Abstract][Full Text] [Related]
12. Serum beta-2 microglobulin levels are a significant prognostic factor in Philadelphia chromosome-positive chronic myelogenous leukemia.
Rodriguez J; Cortes J; Talpaz M; O'Brien S; Smith TL; Rios MB; Kantarjian H
Clin Cancer Res; 2000 Jan; 6(1):147-52. PubMed ID: 10656443
[TBL] [Abstract][Full Text] [Related]
13. Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase: comparison with historic data.
Kantarjian HM; O'Brien S; Cortes J; Giles FJ; Rios MB; Shan J; Faderl S; Garcia-Manero G; Ferrajoli A; Verstovsek S; Wierda W; Keating M; Talpaz M
Cancer; 2003 Dec; 98(12):2636-42. PubMed ID: 14669283
[TBL] [Abstract][Full Text] [Related]
14. The impact of the combination of baseline risk group and cytogenetic response on the survival of patients with chronic myeloid leukemia treated with interferon alpha.
Hasford J; Pfirrmann M; Shepherd P; Guilhot J; Hehlmann R; Mahon FX; Kluin-Nelemans HC; Ohnishi K; Steegmann JL; Thaler J
Haematologica; 2005 Mar; 90(3):335-40. PubMed ID: 15749665
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.
Aschan J; Ringdén O
Clin Transplant; 1994 Jun; 8(3 Pt 1):258-70. PubMed ID: 8061365
[TBL] [Abstract][Full Text] [Related]
16. [Study of deletion of derivative chromosome 9 in patients with Ph+ chronic myeloid leukemia].
Wu W; Xue YQ; Wu YF; Pan JL; Shen J
Zhonghua Xue Ye Xue Za Zhi; 2006 Mar; 27(3):183-6. PubMed ID: 16792921
[TBL] [Abstract][Full Text] [Related]
17. Effects of age on prognosis with imatinib mesylate therapy for patients with Philadelphia chromosome-positive chronic myelogenous leukemia.
Cortes J; Talpaz M; O'Brien S; Giles F; Beth Rios M; Shan J; Faderl S; Garcia-Manero G; Ferrajoli A; Wierda W; Kantarjian H
Cancer; 2003 Sep; 98(6):1105-13. PubMed ID: 12973833
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic analysis of chronic myeloid leukemia with Cox model and the Sokal, Hasford score].
Gan DY; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):662-6. PubMed ID: 16928295
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
[TBL] [Abstract][Full Text] [Related]
20. Haploidentical family member transplants for patients with chronic myeloid leukaemia: a report of the Chronic Leukaemia Working Party of off European Group for Blood and Marrow Transplantation (EBMT).
Speiser DE; Hermans J; van Biezen A; Starobinski M; Jeannet M; Jacobsen N; Niederwieser D; Gratwohl A; Apperley JF
Bone Marrow Transplant; 1997 Jun; 19(12):1197-203. PubMed ID: 9208113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]